Sivik Global Healthcare LLC boosted its position in shares of West Pharmaceutical Services, Inc. (NYSE:WST - Free Report) by 30.8% in the 3rd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 17,000 shares of the medical instruments supplier's stock after buying an additional 4,000 shares during the quarter. West Pharmaceutical Services accounts for approximately 2.2% of Sivik Global Healthcare LLC's investment portfolio, making the stock its 21st largest position. Sivik Global Healthcare LLC's holdings in West Pharmaceutical Services were worth $5,103,000 at the end of the most recent reporting period.
A number of other hedge funds have also bought and sold shares of WST. Kayne Anderson Rudnick Investment Management LLC increased its stake in West Pharmaceutical Services by 6.8% in the second quarter. Kayne Anderson Rudnick Investment Management LLC now owns 593,692 shares of the medical instruments supplier's stock worth $195,556,000 after purchasing an additional 37,702 shares during the period. Sei Investments Co. increased its stake in West Pharmaceutical Services by 12.7% in the 2nd quarter. Sei Investments Co. now owns 401,026 shares of the medical instruments supplier's stock worth $132,095,000 after buying an additional 45,208 shares during the period. Envestnet Asset Management Inc. lifted its holdings in West Pharmaceutical Services by 9.8% during the 2nd quarter. Envestnet Asset Management Inc. now owns 301,339 shares of the medical instruments supplier's stock valued at $99,258,000 after buying an additional 26,947 shares in the last quarter. Dimensional Fund Advisors LP boosted its position in West Pharmaceutical Services by 11.7% in the 2nd quarter. Dimensional Fund Advisors LP now owns 288,639 shares of the medical instruments supplier's stock valued at $95,075,000 after buying an additional 30,253 shares during the period. Finally, Epoch Investment Partners Inc. grew its stake in West Pharmaceutical Services by 3.5% in the 2nd quarter. Epoch Investment Partners Inc. now owns 269,675 shares of the medical instruments supplier's stock worth $88,828,000 after acquiring an additional 9,156 shares in the last quarter. Institutional investors own 93.90% of the company's stock.
West Pharmaceutical Services Trading Down 1.7 %
Shares of NYSE:WST traded down $5.88 during trading on Thursday, reaching $338.12. 572,135 shares of the company were exchanged, compared to its average volume of 571,904. The business's fifty day simple moving average is $304.87 and its 200-day simple moving average is $316.60. The company has a debt-to-equity ratio of 0.07, a current ratio of 3.00 and a quick ratio of 2.23. West Pharmaceutical Services, Inc. has a 12-month low of $265.00 and a 12-month high of $413.70. The firm has a market capitalization of $24.49 billion, a PE ratio of 51.06, a P/E/G ratio of 24.78 and a beta of 1.00.
West Pharmaceutical Services (NYSE:WST - Get Free Report) last posted its earnings results on Thursday, October 24th. The medical instruments supplier reported $1.85 EPS for the quarter, beating analysts' consensus estimates of $1.50 by $0.35. The business had revenue of $746.90 million for the quarter, compared to the consensus estimate of $709.62 million. West Pharmaceutical Services had a net margin of 17.37% and a return on equity of 18.41%. The company's revenue for the quarter was down .1% on a year-over-year basis. During the same quarter last year, the firm posted $2.16 EPS. On average, research analysts anticipate that West Pharmaceutical Services, Inc. will post 6.66 EPS for the current year.
West Pharmaceutical Services Increases Dividend
The firm also recently declared a quarterly dividend, which will be paid on Wednesday, November 20th. Shareholders of record on Wednesday, November 13th will be paid a $0.21 dividend. The ex-dividend date of this dividend is Wednesday, November 13th. This is a boost from West Pharmaceutical Services's previous quarterly dividend of $0.20. This represents a $0.84 dividend on an annualized basis and a yield of 0.25%. West Pharmaceutical Services's dividend payout ratio (DPR) is 11.87%.
Insiders Place Their Bets
In other West Pharmaceutical Services news, VP Charles Witherspoon sold 703 shares of the firm's stock in a transaction that occurred on Tuesday, October 29th. The shares were sold at an average price of $310.40, for a total transaction of $218,211.20. Following the completion of the transaction, the vice president now directly owns 1,253 shares of the company's stock, valued at approximately $388,931.20. This trade represents a 35.94 % decrease in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. Corporate insiders own 0.53% of the company's stock.
West Pharmaceutical Services Profile
(
Free Report)
West Pharmaceutical Services, Inc designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products.
Featured Articles
Before you consider West Pharmaceutical Services, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and West Pharmaceutical Services wasn't on the list.
While West Pharmaceutical Services currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking to generate income with your stock portfolio? Use these ten stocks to generate a safe and reliable source of investment income.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
